Sort
51,593 grants matching “hepatitis”
Computer Analysis of Nucleic Acid Structure
$842,930Bruce A. Shapiro · Basic Sciences · Z01 · FY2007 · CA
TASK A92: Efficacy testing of therapeutics against Hepatitis B in a mouse model
$842,763Norman Kneteman · Kmt Hepatech Inc · N01 · FY2016 · AI
A Multi-Center Study of Acute Liver Failure in Adults
$842,667William M Lee · Ut Southwestern Medical Center · U01 · FY2008 · DK
Role Of Monocytes In AIDS And As Targets For Antiviral Therapy
$842,606Sharon M Wahl · National Institute Of Dental & Craniofacial Research · ZIA · FY2010 · DE
Studies of HCV Infection And HCV-Host interactions
$842,027Tsanyang Liang · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2013 · DK
Giant MagnetoResistive (GMR) Sensors for Measuring Influenza Vaccine
$842,000Paul Joseph Utz · Stanford University · R01 · FY2020 · AI
Role of innate immunity in HIV related vascular disease: biomarkers & mechanisms
$841,929Robert C Kaplan · Albert Einstein College Of Medicine, Inc · R01 · FY2016 · HL
Small Molecule Therapeutics for Renal Disease
$841,379Prakash Narayan · Angion Biomedica Corporation · R44 · FY2009 · DK
Drug Abuse Treatment System Survey
$841,359Jeffrey A Alexander · University Of Michigan At Ann Arbor · R01 · FY2006 · DA
Biochemical and Genetic Markers of Type 2 Diabetes Risk
$841,303Frank B Hu · Brigham And Women'S Hospital · R01 · FY2010 · DK
Low Cost Multi-pathogen Laser Diagnostic for HIV and AIDS Co-Infections
$841,216Christopher John Myatt · Precision Photonics Corporation (Ppc) · R44 · FY2009 · AI
Innate Immunity Stimulation Effects on Biomarkers, Cognition, and the Vascular Amyloid Proteome in a Squirrel Monkey Model of Sporadic CAA
$841,182Henrieta Scholtzova · New York University School Of Medicine · R01 · FY2022 · NS
Elucidating the Molecular Mechanisms that Mediate DKD Progression in Patients Living with HIV
$841,127John C He · Icahn School Of Medicine At Mount Sinai · R01 · FY2023 · DK
Elucidating the Molecular Mechanisms that Mediate DKD Progression in Patients Living with HIV
$841,127John C He · Icahn School Of Medicine At Mount Sinai · R01 · FY2025 · DK
Novel non-narcotic analgesic for acute and chronic pain
$840,427Nicolas Guillermo Bazan · South Rampart Pharma, Llc · R42 · FY2021 · NS
Novel non-narcotic analgesic for acute and chronic pain
$840,427Nicolas Guillermo Bazan · South Rampart Pharma, Llc · R42 · FY2022 · NS
Role of PreS2 Mutants in Pathogenesis of Chronic Hepatitis B
$840,347Lynn Pulliam · Northern California Institute/Res/Edu · R01 · FY2009 · CA
Towards Evidence-Based Monitoring of Low Dose Methotrexate: CIRT Ancillary Study
$840,301Daniel Hal Solomon · Brigham And Women'S Hospital · R01 · FY2017 · HL
Systems Biology of Immune Reconstitution in HIV / AIDS
$840,263Dana H. Gabuzda · Dana-Farber Cancer Inst · DP1 · FY2011 · DA
Systems Biology of Immune Reconstitution in HIV / AIDS
$840,263Dana H. Gabuzda · Dana-Farber Cancer Inst · DP1 · FY2014 · DA
New insights into the functional diversity of the hepatic antiviral T cell response during hepacivirus infection in vivo
$840,000Eva Billerbeck · Albert Einstein College Of Medicine · R01 · FY2025 · AI
Control of Cholesterol Metabolism --Bile Acid Transport
$839,954John M. Dietschy · Ut Southwestern Medical Center · R01 · FY2009 · HL
Antigen-Specific NK Cell Memory Against SIV and HIV Vaccines
$839,952Roger Keith Reeves · Beth Israel Deaconess Medical Center · R01 · FY2020 · AI
Search For New and Emerging Etiologic Agents
$839,842Robert H. Purcell · National Institute Of Allergy And Infectious Diseases · ZIA · FY2011 · AI
Pharmacogenomics and Systems Pharmacology Approaches to Toxicity, Tolerability, and Comorbidities Associated with Modern Antiretroviral Therapies
$839,731Inga Peter · Icahn School Of Medicine At Mount Sinai · R01 · FY2019 · HG